000 01791 a2200517 4500
005 20250517000118.0
264 0 _c20150626
008 201506s 0 0 eng d
022 _a1757-4684
024 7 _a10.15252/emmm.201403967
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMojumdar, Kamalika
245 0 0 _aInflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2.
_h[electronic resource]
260 _bEMBO molecular medicine
_cNov 2014
300 _a1476-92 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntigens, Ly
_xanalysis
650 0 4 _aCD11b Antigen
_xanalysis
650 0 4 _aChemokine CCL2
_xmetabolism
650 0 4 _aDiaphragm
_xpathology
650 0 4 _aFemale
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMale
650 0 4 _aMesenchymal Stem Cell Transplantation
650 0 4 _aMesenchymal Stem Cells
_xmetabolism
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Inbred mdx
650 0 4 _aMonocytes
_xchemistry
650 0 4 _aMuscular Dystrophy, Duchenne
_ximmunology
650 0 4 _aMutant Proteins
_xmetabolism
650 0 4 _aReceptors, CCR2
_xantagonists & inhibitors
650 0 4 _aTreatment Outcome
700 1 _aLiang, Feng
700 1 _aGiordano, Christian
700 1 _aLemaire, Christian
700 1 _aDanialou, Gawiyou
700 1 _aOkazaki, Tatsuma
700 1 _aBourdon, Johanne
700 1 _aRafei, Moutih
700 1 _aGalipeau, Jacques
700 1 _aDivangahi, Maziar
700 1 _aPetrof, Basil J
773 0 _tEMBO molecular medicine
_gvol. 6
_gno. 11
_gp. 1476-92
856 4 0 _uhttps://doi.org/10.15252/emmm.201403967
_zAvailable from publisher's website
999 _c24275903
_d24275903